arthritis
Research roundup
Debbie Rigby takes a look at the latest in research news Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis A US position statement on the prevalence of SGLT-2–associated DKA suggests that …
Arthritis isn’t just a condition affecting older people, it likely starts much earlier
Arthritis isn’t just a condition affecting older people, it likely starts much earlier Flavia Cicuttini, Monash University This article is part of our series on older people’s health. It looks …
Inclement weather not to blame for aches and pains
Changes in the weather are not connected with back pain or osteoarthritis symptoms, Australian researchers have concluded A study comparing weather patterns with pain symptoms has shown no association between …
Arthritis/continence link
Next week is Arthritis Week presenting an opportunity to highlight the connection between arthritis and continence issues. While arthritis doesn’t directly affect bladder or bowel function, incontinence associated with arthritis …
Allied health has strong role in osteoarthritis
After a diagnosis of osteoarthritis, women tend to reduce doctor visits in favour of allied health professionals, a new analysis has found. UniSA School of Pharmacy and Medical Sciences Senior …
Panadol Osteo decision could shift patients to opioids
Stakeholders have expressed disappointment in the PBAC’s restatement of its decision to delist Panadol Osteo, and concerns that patients may turn to stronger alternatives to manage their pain. The PBAC …
Clinical tips: osteoarthritis
It may be time to change your thinking about osteoarthritis, writes Ben Basger Osteoarthritis is the leading musculoskeletal cause of disability in Western society. It is the most common form …
Reconsider Panadol Osteo delisting in light of risks: Painaustralia
The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …
Why pharmacists need to change their thinking
The expanding role of community pharmacists—from making medicines to optimising outcomes—will require a shift in thinking, writes Vanessa Lontos Recently the International Pharmaceutical Federation (FIP), whose role is to advance …
Knee and back pain review needed following waste revelations
Arthritis Australia is calling for an urgent review of care arrangements for people with knee and back pain following a Four Corners report that millions of health dollars are being …
Rheumatoid arthritis treatment in new class of medicines
A new oral treatment alternative for patients with moderate to severe rheumatoid arthritis, will be available on the PBS from 1 October, 2015.
Back pain and arthritis costs more than $14 billion
Research published in the Medical Journal of Australia today confirms that lost productivity due to back pain and arthritis currently costs Australia more than $14 billion a year and will …